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Abstract
 
Lipopolysaccharide (LPS), a product of Gram-negative bacteria, is potent mediator of tumor
 
necrosis factor (TNF)
 
  
 
production by myeloid/macrophage cells. Inhibitors capable of block-
ing the signaling events that result in TNF
 
  
 
production could provide useful therapeutics for
treating septic shock and other inflammatory diseases. Broad spectrum tyrosine inhibitors are
known to inhibit TNF
 
  
 
production, however, no particular family of tyrosine kinases has been
shown to be essential for this process. Here we show that the Bruton’s tyrosine kinase (Btk)-
deficient mononuclear cells from X-linked agammaglobulinemia patients have impaired LPS-
induced TNF
 
  
 
production and that LPS rapidly induces Btk kinase activity in normal mono-
cytes. In addition, adenoviral overexpression of Btk in normal human monocytes enhanced
TNF
 
  
 
production. We examined the role of Btk in TNF
 
  
 
production using luciferase reporter
adenoviral constructs and have established that overexpression of Btk results in the stabilization
of TNF
 
  
 
mRNA via the 3
 
  
 
untranslated region. Stimulation with LPS also induced the activa-
tion of related tyrosine kinase, Tec, suggesting that the Tec family kinases are important com-
ponents for LPS-induced TNF
 
  
 
production. This study provides the first clear evidence that
tyrosine kinases of the Tec family, in particular Btk, are key elements of LPS-induced TNF
 
 
 
production and consequently may provide valuable therapeutic targets for intervention in
inflammatory conditions.
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Introduction
 
TNF
 
  
 
is a proinflammatory cytokine pivotal to the patho-
genesis of chronic inflammatory diseases such as rheuma-
toid arthritis and Crohn’s disease (1), and in inflammatory
responses such as leukocyte migration, tissue resorption,
the acute-phase response, and fever (2). The major produc-
ers of TNF
 
  
 
are cells of the mononuclear phagocyte lin-
eage including macrophages, microglia, osteoclasts, and
myeloid dendritic cells. Despite considerable efforts, rela-
 
tively few signaling molecules, e.g., nuclear factor (NF)
 
*
 
-
 
 
 
B
(3, 4) and p38 MAPK/MK2 (5, 6), have been shown to be
essential for TNF
 
  
 
expression in macrophages. It is well
documented that tyrosine kinase inhibitors are potent sup-
pressors of LPS-induced TNF
 
  
 
production (7, 8) and that
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Abbreviations used in this paper:
 
 AdBtk, adenovirus-encoding human Bru-
ton’s tyrosine kinase; ARE, AU-rich element; Btk, Bruton’s tyrosine ki-
 
nase; I
 
 
 
B
 
 
 
, inhibitory protein 
 
 
 
B
 
 
 
; MAPK, mitogen-activated protein
kinase; m.o.i., multiplicity of infection; NF, nuclear factor; UTR, un-
 
translated region; 
 
xid
 
, X-linked immunodeficiency; XLA, X-linked agam-
maglobulinemia.T
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Btk Modulates TNF
 
 
 
 Production
 
the activation of tyrosine kinase activity is one of the earli-
est detectable events after LPS stimulation of monocytic
cells (9–11). However, defining a causal relationship be-
tween a particular tyrosine kinase and TNF
 
  
 
production
has been difficult. LPS can activate the Src family kinases
p58
 
hck
 
, p53
 
lyn
 
, and p59
 
fgr
 
, as well as p72
 
syk 
 
(12–14), yet mac-
rophages from mice deficient in these kinases do not show
any impairment of LPS-induced TNF
 
  
 
production (15,
16). LPS has also been shown to activate the tyrosine kinase
Pyk-2 (17), but its role, if any, in TNF
 
  
 
production has yet
to be elucidated.
Another family of nonreceptor tyrosine kinases ex-
pressed by monocytic cells is the Tec family, and in par-
ticular, Bruton’s tyrosine kinase (Btk). Recent studies
have shown that the Tec family kinases are important
components of both antigen receptor signaling and other
cell surface receptors, resulting in the activation of nu-
merous signal transduction pathways, regulation of the
actin cytoskeleton, adhesion, migration, and transcrip-
tional activation (18). Btk is found in all cells of the he-
matopoietic lineage except plasma and T cells (19), and is
required for normal B cell development and signal trans-
duction through cell surface molecules (20). Mutations in
the 
 
btk
 
 gene result in aberrant B cell development, lead-
ing to the X-linked agammaglobulinemia (XLA) pheno-
type in humans and to the less severe X-linked im-
munodeficiency (
 
xid
 
) in mice. 
 
xid
 
 B cells show some
hyporesponsiveness to LPS stimulation, although the
precise cause has not been established (21, 22). Because
the major phenotype of Btk deficiency is impaired B cell
development and function, this cell type has been the
major focus of interest to date. Earlier studies performed
on 
 
xid 
 
mononuclear cells showed no obvious impairment
of TNF
 
  
 
production in response to a series of inflamma-
tory stimuli such as LPS and formalin-killed 
 
Staphylococcus
aureus
 
 (23). However, bone marrow–derived cultured
mast cells from 
 
xid
 
 mice have been shown to produce less
TNF
 
  
 
in passive cutaneous anaphylactic reactions (24)
and there is a recent report that 
 
xid
 
 peritoneal macro-
phages express reduced levels of TNF
 
  
 
and IL-1
 
  
 
in re-
sponse to LPS (25). Additionally, 
 
xid
 
 mice are resistant to
models of autoimmune diseases, e.g., collagen-induced
arthritis (26, 27).
In humans, XLA is characterized by the absence of ma-
ture B cells in the periphery with a marked reduction in
serum levels of all Ig isotypes resulting in a susceptibility
to recurrent and severe bacterial infections (20, 28). Yet
despite lacking Btk, XLA monocytes appear to develop
normally and are present in expected numbers in the cir-
culation. The importance of Btk in human monocyte/
macrophages remains to be fully elucidated. As the XLA
phenotype differs from that of the 
 
xid
 
 mice, we have ex-
amined the responses of XLA monocytes and macro-
phages to LPS stimulation. In addition, we have used an
adenovirus expressing Btk in conjunction with TNF
 
  
 
lu-
ciferase reporter adenoviruses to analyze the contribution
of Btk-dependent signaling events to the regulation of
TNF
 
  
 
production.
 
Materials and Methods
 
Isolation and Culture of Cells
 
Isolation and Culture of PBMCs from XLA and Control Donors.
 
Human blood samples were collected into lithium heparin vacu-
tainers. Each blood sample was mixed with an equal volume of
HBSS. PBMCs were prepared by ficoll-hypaque centrifugation
on a lymphoprep gradient. PBMCs were cultured in RPMI con-
taining 100 units/ml penicillin/streptomycin and 10% heat-inac-
tivated FCS at 37
 
 
 
C in a humidified atmosphere containing 5%
CO
 
2
 
. Monocytes were isolated from the PBMCs by adherence to
plastic for 1 h at 37
 
 
 
C in RPMI containing 100 units/ml penicil-
lin/streptomycin and 10% FCS. Nonadherent cells were then
washed off and the adherent monocytes were rested overnight
and stimulated with LPS. B cells were depleted from PBMC us-
ing Dynabeads
 
® 
 
coated with anti-CD19 antibodies. Cells were
incubated with the beads for 1 h with constant agitation at 4
 
 
 
C.
The beads were then magnetically removed and the remaining
cells were subjected to FACS
 
® 
 
analysis with FITC-conjugated
anti-CD19 resulting in 
 
 
 
90% B cell depletion.
 
Isolation of Monocytes by Elutriation.
 
PBMCs were prepared
from buffy coat fractions of a unit of blood from a single donor
using ficoll-hypaque. The monocytes were then isolated by cen-
trifugal elutriation as previously described (4). Monocyte frac-
tions of 
 
 
 
85% purity were routinely collected in this manner.
Monocytes were cultured in RPMI containing 100 units/ml
penicillin/streptomycin and 10% heat-inactivated FCS at 37
 
 
 
C
in a humidified atmosphere containing 5% CO
 
2
 
. For adenoviral
infection, monocytes were treated with 100 ng/ml M-CSF (pro-
vided by G. Larsen, Genetics Institute, Boston, MA) for 72 h be-
fore viral infection.
 
Generation of Adenoviral Vectors and Cell Infection.
 
Recombi-
nant, replication-deficient adenoviral constructs encoding wild-
type human Btk (AdBtk; cDNA provided by C. Kinnon, Insti-
tute of Child Health, London, United Kingdom) were prepared
using the AdEasy system as previously described (29). In short,
recombinant viral DNA was transfected into 293 cells in 6-well
tissue culture plates using lipofectamine (GIBCO BRL) accord-
ing to the manufacturer’s instructions. Cells were overlaid with
2% agarose/DMEM 24 h after transfection and viral plaques
were picked after 9–10 d. Viral clones were propagated in 293
cells and screened for transgene expression by Western blotting.
Clonal viruses were then prepared from 20 175 cm
 
3 
 
tissue cul-
ture flasks of 293 cells by ultracentrifugation through two cae-
sium chloride gradients. Titres of viral stocks were determined
by plaque assay and viral aliquots were stored at 
 
 
 
70
 
 
 
C. The
AdGFP adenovirus was prepared according to this protocol us-
ing AdTrackGFP with no insert. AdTrack0 (Ad0), pAdTrack-
TNF 5
 
  
 
promoter-Luc-3
 
  
 
untranslated region (UTR; Ad5
 
 
 
3
 
 
 
luc),
and pAdTrack-TNF 5
 
  
 
promoter-Luc (Ad5
 
 
 
luc) were generated
as previously described (30). The NF-
 
 
 
B luciferase adenovirus
(AdNF-
 
 
 
B-luc) contains four tandem copies of the 
 
  
 
enhancer
element located upstream of the firefly luciferase gene (31). This
adenovirus was provided by P.B. McCray Jr. (University of
Iowa, Iowa City, IA) and is a modification of the pNF-
 
 
 
B re-
porter vector (BD Clontech). Recombinant adenoviral vectors
encoding 
 
Escherichia coli
 
 
 
 
 
-galactosidase (Ad
 
 
 
gal) were provided
by M. Woods and A. Bryne (Oxford University, Oxford, United
Kingdom).
M-CSF–derived monocytes were plated in 96-well plates at
1.5 
 
  
 
10
 
5 
 
cells/well and allowed to settle for at least 4 h. The
cells were washed in serum-free RPMI medium and then ex-
posed to virus at different multiplicity of infection (m.o.i.) for 2 hT
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in serum-free RPMI at 37
 
 
 
C, after which cells were washed in
RPMI and cultured in complete medium for 24 h before stimu-
lation with LPS as previously described (4).
 
Immunoprecipitation and In Vitro Kinase Assay.
 
Btk autokinase
activity was measured in response to LPS in primary human
monocytes. Cells were stimulated with LPS for various times as
detailed. Cells were pelleted by centrifugation and lysed for 20
min on ice with 1% NP-40 lysis buffer containing 20 mM Tris,
pH 8, 130 mM NaCl, 10 mM NaF, 1 mM DTT, 20 
 
 
 
M leupep-
tin, 100 
 
 
 
M sodium orthovanadate, 1 mM PMSF, 10 
 
 
 
M E64,
and 2 mg/ml aprotinin. Lysates were microfuged for 10 min at
13,000 rpm at 4
 
 
 
C and supernatants were removed and pre-
cleared for 30 min at 4
 
 
 
C in 20 
 
 
 
l protein A–sepharose (previ-
ously washed in lysis buffer). After centrifuging the samples for 10
min at 1,300 rpm, the supernatants were removed and incubated
with 2 
 
 
 
l rabbit polyclonal anti–Btk (provided C. Kinnon, Insti-
tute of Child Health, London, United Kingdom) for 1 h at 4
 
 
 
C.
30 
 
 
 
l protein A–sepharose was then added to each sample and
incubated for an additional 1.5 h at 4
 
 
 
C. The beads were then
washed three times in lysis buffer and once in kinase buffer (10
mM MgCl
 
2
 
; 10 mM MnCl
 
2
 
). Beads were mixed with kinase
buffer containing 
 
 
 
32
 
P[ATP] and incubated for 15 min at room
temperature. The reaction was stopped by the addition of 4
 
 
 
Laemmli buffer and the samples were boiled for 10 min. Samples
were electrophoresed on an 8% SDS polyacrylamide gel. The gel
was stained, fixed, dried, and autoradiographed. Tec autokinase
activity was measured as previously described (32). Tec protein
was immunoprecipitated, either with rabbit anti–Tec serum (32)
or goat polyclonal anti–Tec (Santa Cruz Biotechnology, Inc.).
 
Western Blot Analysis.
 
Cells were lysed in lysis buffer and de-
bris pelleted as described above. Lysate protein concentration was
assessed by Bradford assay and equivalent amounts of lysate pro-
tein were electrophoresed on 8% SDS polyacrylamide gels, fol-
lowed by electrotransfer of proteins onto nitrocellulose mem-
branes. Membranes were blocked in 10% Marvel/PBS/Tween
(0.05%) and probed with either rabbit polyclonal anti–Btk (BD
Biosciences) at 1 
 
 
 
g/ml in 5% Marvel/PBS/Tween (0.05%),
anti–inhibitory protein 
 
 
 
B
 
  
 
(I B ; Santa Cruz Biotechnology,
Inc.), anti-p54/JNK (Santa Cruz Biotechnology, Inc.), or rabbit
anti–Tec for 2 h. After washing, membranes were incubated with
anti–rabbit horseradish peroxidase at 1:5,000 in 5% Marvel/PBS/
Tween (0.05%). After washing in PBS/Tween (0.05%), the
membranes were developed using enhanced chemiluminescence
according to the manufacturer’s instructions (Amersham Bio-
sciences).
ELISA. Supernatants were harvested 18 h after stimulation
of human macrophages or PBMCs. The concentration of TNF 
(BD Biosciences) was determined by ELISA according to the
manufacturer’s instruction. Absorbance was read and analyzed at
450 nM on a spectrophotometric ELISA plate reader (Labsystems
Multiskan Biochromic) using the Ascent 2.4.2 software program.
Results are expressed as the mean concentration of triplicate cul-
tures  SD.
Luciferase Assays. After LPS stimulation, cells were washed
once in PBS and lysed with 100  l CAT lysis buffer (0.65% [vol/
vol] of NP-40, 10 mM Tris-HCl, pH 8, 0.1 mM EDTA, pH 8,
150 mM NaCl). 50  l cell lysate were transferred into the well of
a luminometer cuvette strip containing 120  l luciferase assay
buffer. Luciferase activity was measured with a Labsystem Lumi-
nometer by dispensing 30  l luciferin (Bright-Glo luciferase assay
system; Promega) per assay point. Cell lysates were assayed for
protein concentration by Bradford assay and luciferase activity was
adjusted accordingly.
Taqman RT-PCR. M-CSF–treated monocytes were plated at
5    105 cells/well in 24-well plates and infected as described
above. Total RNA was extracted using RNeasy Kit (QIAGEN)
according to the manufacturer’s instructions. All semiquantitative
RT-PCR was performed using an ABI PRISM 7700 Sequence
Detection System, Taqman One Step RT-PCR reagent, and
TNF , IL-6, and GAPDH predeveloped assay reagents (Perkin-
Elmer). ABI PRISM 7700 Sequence detector was programmed
for the RT step of 30 min at 48 C followed by a 5-min deactiva-
tion step at 95 C. Subsequent PCR amplification consisted of 40
cycles of denaturation at 94 C for 15 s and annealing/extension at
60 C for 60 s. The cycle number at which the amplification plot
crosses a fixed threshold above baseline is defined as threshold cy-
cle (Ct). To control variation in mRNA concentration, all results
were normalized to the housekeeping gene, GAPDH. Relative
quantitation was performed using the comparative   Ct method
according to the manufacturer’s instructions.
Results
Btk Deficiency Results in Impaired TNF  Production. PBMCs
from XLA blood were used to see if Btk deficiency had
any effect on LPS-induced TNF   production. When
compared with PBMC from normal age and sex-matched
controls, the LPS response of XLA cells was impaired. At
the lowest dose of LPS (0.1 ng/ml), XLA and normal PB-
MCs produced similar levels of TNF , but increasing con-
centrations of LPS failed to generate the increased response
seen in the normal cells. At 10 ng/ml, LPS-induced TNF 
production by XLA PBMCs was only 15% of the control
cells, whereas at 100 ng/ml LPS the response was only 10%
of control (Fig. 1 A). Although B cells are not known to
produce TNF  in response to LPS, the involvement of
B cells from the normal PBMCs in LPS-induced TNF 
production was investigated to negate any secondary effects
due to the absence of B cells in XLA PBMCs. Depleting
B cells from normal PBMC showed no effect on LPS-
induced TNF  production (Fig. 1 B). Furthermore, we
found that the T cells, the major component of PBMCs,
did not produce TNF  in response to LPS (unpublished
data) and these cells do not express Btk (33). Although the
amount of blood available made purifying the monocytes
from XLA blood difficult, we managed to separate the
monocytic cells using adherence. LPS-induced TNF  pro-
duction was again significantly reduced, although at 50% of
normal controls, the impairment was not as great as seen in
PBMCs (Fig. 1 C).
Stimulation with LPS Induces Btk Kinase Activity In Vitro.
To further establish a role for Btk in LPS-induced TNF 
production, we attempted to determine whether LPS was
able to regulate Btk activity. Autokinase assays of enzyme
immunoprecipitated from human primary monocytes dem-
onstrated that LPS could rapidly activate Btk (Fig. 2 A).
Btk autokinase activity was also observed in the murine
macrophage cell line RAW 264.7 after LPS stimulation
(unpublished data). Additionally, the effect of overexpres-
sion of Btk was examined by infecting 48-h M-CSF–
treated monocytes (4) with increasing amounts of adeno-
virus-encoding human Btk (AdBtk). Infection with AdBtkT
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alone did not induce TNF  production (unpublished data).
However, infection with increasing amounts of virus syn-
ergized with LPS to increase TNF  expression, resulting in
a two- to threefold increase in TNF  at the highest m.o.i.
of 100 (Fig. 2 B). This effect correlated with the increased
amounts of Btk protein seen in the infected cells (Fig. 2 C).
No effect on TNF  production was seen with control vi-
ruses encoding either  -galactosidase or Pyk2, another
LPS-activated tyrosine kinase (17), at the highest m.o.i. of
100 (Fig. 2 B).
LPS-induced I B  Degradation Is Intact in XLA PBMCs.
Overall, the data strongly suggested that there was a role for
Btk in LPS-induced TNF  production. However, there
was the possibility that this was the result of some develop-
ment defect, rather than a direct effect of an absent kinase.
As others have reported (34), FACS® analysis showed no
impairment of CD14 expression, a component of the LPS
binding on XLA monocytes (unpublished data). We also
used the LPS-induced degradation of I B  as a measure of
signaling function, as this event does not appear to require
tyrosine kinase activity (35, 36) and therefore should be in-
tact. As shown in Fig. 3 A, there was a similar degradation
of I B  in XLA and normal monocytes in response to LPS,
indicating no obvious impairment of the NF- B activation
pathway. We further investigated the involvement of the
NF- B signaling pathway by coinfecting M-CSF–treated
monocytes with AdBtk and an NF- B reporter virus that
encodes luciferase under the control of a series of NF- B
binding sites (31). M-CSF monocytes were simultaneously
infected with these viruses and controls, and the luciferase
activity and TNF  production were measured after 18 h of
LPS stimulation. Although we still observed an increase in
TNF  production in these cultures (Fig. 3 C), there was no
corresponding increase in luciferase activity (Fig. 3 B), indi-
cating that Btk was able to promote TNF  production in-
dependently of the NF- B activation.
Overexpression of Btk Acts via the 3  UTR of TNF mRNA.
To establish the mechanism of Btk action on TNF  pro-
duction, the activity of the human TNF promoter in stim-
ulated human macrophages was studied using 5  promoter-
luciferase and 5  promoter-luciferase-3  UTR adenoviral
TNF gene reporter constructs (30). Primary human macro-
phages were simultaneously infected with reporter viruses
at an m.o.i. of 40, whereas the Ad0 or AdBtk were used at
an m.o.i. of 100. 24 h after adenoviral infection, macro-
phages were treated with LPS or left unstimulated for 18 h
before assay of luciferase activity and ELISA for TNF  pro-
Figure 1. LPS-induced TNF  expression in PBMCs/monocytes from
XLA and normal donors. (A) PBMCs from XLA and normal male donors
(age range 17–38 yr). (B) Total PBMCs and PBMCs depleted of B cells
from normal donors. (C) Monocytes prepared by adherence from normal
and XLA PBMCs. Cells were stimulated with 10 ng/ml LPS (unless oth-
erwise stated) for 18 h and supernatants were assayed for TNF  produc-
tion by ELISA. In A, each point represents a donor, B is representative of
three separate experiments, and C shows the combined results of five do-
nors of each type (error bars   SD). Results from Student’s t test P values:
*, P   0.05; **, P   0.01; ***, P   0.001. TNF  production from unac-
tivated cells was undetectable.
Figure 2. Btk is activated by LPS stimulation and modulates TNF 
production. (A) Primary monocytes were stimulated with LPS for the in-
dicated intervals. Cell lysates were immunoprecipitated and immune
complex kinase assays were performed. Autophosphorylated Btk proteins
were detected by autoradiography. This result is representative of three
separate experiments. (B) Monocytes were infected with adenoviruses en-
coding either wild-type Btk (Btk WT),  -galactosidase ( -Gal), or an un-
related tyrosine kinase, Pyk2. Cells were stimulated with LPS for 18 h
and the supernatants were assayed for TNF  expression. Data is presented
as fold activation compared with uninfected LPS stimulated control cells
( SD). *, P   0.05; **, P   0.01 compared with LPS-activated unin-
fected controls. (C) Cell lysates from the infected cells were examined for
Btk expression by immuno-Western blotting. Data is representative of at
least four different donors.T
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duction. There was a threefold increase in luciferase activ-
ity in the cells containing the TNF5  3  UTR reporter
construct compared with the Ad0 control cells (Fig. 4 A).
However, there was no enhancement of luciferase activity
from the TNF 5  promoter construct (Fig. 4 C). Overex-
pression of Btk enhanced LPS-stimulated TNF  produc-
tion by threefold in the presence of either TNF reporter
construct (Fig. 4, B and D). There was no significant differ-
ence in TNF production and luciferase activity when com-
paring Ad0-infected macrophages with controls infected
with the reporter constructs alone. The lack of enhanced
luciferase activity from the 5  promoter construct after LPS
stimulation indicated that the 3  UTR of TNF  mRNA
was required for the action of Btk.
Overexpression of Btk Leads to Stabilization of TNF  mRNA.
The importance of the 3  UTR in the stability of TNF 
mRNA has been studied extensively (37, 38). Because Btk
appeared to be acting via the 3  UTR, it seemed likely that
it was also affecting the stability of TNF  mRNA. To fur-
ther analyze the mechanism by which Btk determines the
levels of TNF , we blocked transcription in LPS-stimu-
lated M-CSF monocytes by using actinomycin D and ana-
lyzed half-life of TNF   mRNA by Taqman RT-PCR
analysis. As a control, GAPDH mRNA was detected and
used to normalize the TNF  mRNA levels. For each of
the controls, uninfected Ad0 and PykM, the half-life of
TNF  mRNA was  45 min after actinomycin D treat-
ment. However, in the presence of Btk, TNF  mRNA
levels were maintained at 70–100% of the time 0 control
for the duration of the 120-min time course (Fig. 5 A).
These data demonstrate the ability of Btk to stabilize
TNF  mRNA and consequently this may result in the ele-
vated protein expression observed in these cultures.
As the stability of TNF mRNA is known to be associ-
ated with p38 mitogen-activated protein kinase (MAPK)
activation, we examined the ability of PBMCs from XLA
patients to phosphorylate p38 MAPK in response to LPS
treatment. We were able to observe consistently low levels
of p38 MAPK phosphorylation in XLA PBMCs (Fig. 5 B),
however there was considerable variability in the degree of
p38 MAPK phosphorylation from person to person in the
normal controls. There was no difference in p38 MAPK
phosphorylation after LPS treatment of normal PBMCs in
either the presence or absence of B cells (unpublished data).
Due to the limitation of patient samples we were unable to
Figure 3. LPS-induced I B  degradation in XLA and normal PBMCs.
(A) PBMCs stimulated with 10 ng/ml LPS for 20 min were lysed and se-
quentially immunoblotted for the indicated proteins. This result is repre-
sentative of three different experiments. (B and C) M-CSF monocytes
were simultaneously infected with NF- B luciferase reporter construct
(m.o.i. of 100) alone, or coinfected with either AdBtk or Ad0 at various
m.o.i. 24 h after adenoviral infection, cells were treated with LPS for 18 h
before assay of (B) luciferase activity and (C) TNF  production. Data are
means of triplicate cultures   SD and are expressed as a percentage of the
control level. This graph is representative of five experiments performed
using different donors.
Figure 4. Btk overexpression enhances TNF  via the 3  UTR. (A)
Schematic representation of the human TNF 5  promoter-luciferase-3 
UTR and TNF 5  promoter-luciferase adenoviral constructs. Activity of
the human TNF 5  3  UTR (B and C) or TNF 5  promoter (D and E) in
stimulated human macrophages was tested by simultaneously infecting
primary human macrophages with reporter virus at an m.o.i. of 40 and ei-
ther Ad0 or AdBtk at various m.o.i. 24 h after adenoviral infection, mac-
rophages were treated with LPS for 18 h before assay of luciferase activity
(B and D) and TNF  production (C and E). Data are means of triplicate
cultures   SD and are expressed as a percentage of the control level. Each
graph is representative of five experiments performed using different donors.T
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1608 Btk Modulates TNF  Production
examine the kinetics of p38 MAPK activation in XLA pa-
tients compared with normal controls. To further establish
the link between p38 MAPK and Btk, we used adenoviral
overexpression of Btk to determine if there was any in-
crease in p38 MAPK activity in normal M-CSF–treated
monocytes. As shown in Fig. 5 C, we were able to observe
a 1.5–2-fold increase in phosphorylated p38 MAPK.
Tec Is Phosphorylated in Response to LPS. Although we
have demonstrated that Btk is able to modulate TNF  ex-
pression, XLA patients do not show a serious impairment
in their innate immune function. Treatment of XLA
monocytes for 2 d with M-CSF greatly enhanced their
production of TNF  in response to LPS to levels similar
to those obtained with normal monocytes (Fig. 6 A).
Consequently, we examined the mechanism of the in-
creased responsiveness of monocytes after M-CSF treat-
ment. Because members of the Tec family of kinases can
functionally complement each other (39), we tested whether
M-CSF can regulate the expression of an alternative Tec
family kinase to Btk. An obvious candidate was Tec kinase,
as this enzyme is expressed in myeloid cells and does, to
some degree, complement Btk activity in xid B cells (40).
Western immunoblot analysis showed that Tec kinase was
expressed at low levels in untreated monocytes from both
normal donors and XLA patients (Fig. 6 B), however, after
treatment with M-CSF for 48 h the expression of Tec pro-
tein was increased. Counter blots confirmed that the ex-
pression of Btk was restricted to the normal cells (Fig. 6 B).
Next, the response of Tec kinase to LPS in M-CSF–treated
monocytes was investigated using autokinase assays of im-
munoprecipitated enzyme. Like Btk, Tec kinase activity
was increased in response to LPS treatment of human
M-CSF–treated monocytes (Fig. 6 C).
Discussion
Our data has shown that stimulation of human mono-
cytes with LPS triggers the activation of the nonreceptor
tyrosine kinase, Btk. Moreover, in XLA monocytes that
lack functional Btk, there is a failure to respond to LPS
treatment as determined by their reduced TNF  produc-
tion after stimulation. Our initial findings led us to further
examine the contribution of Btk in controlling TNF  pro-
duction. Adenoviral gene transfer has been used extensively
to investigate the role of different transgenes in primary
cells due to the ability of adenoviruses to infect both quies-
cent and dividing cells at high efficiency (4). Overexpres-
sion of Btk resulted in a consistent two- to threefold in-
crease in TNF  production from M-CSF monocytes. In
B cells, activation of the NF- B transcription complex by
signals derived from the B cell antigen receptor act via Btk
to control B cell development, survival, and antigenic re-
sponses. However, the actions of Btk in macrophages ap-
pear to be independent of NF- B activation and there is
no defect in I B  degradation in response to LPS in XLA
monocytes.
TNF biosynthesis is under the control of multiple and
complex regulatory mechanisms. Because the Tec family is
Figure 5. Btk overexpression stabilizes TNF  mRNA.
(A) Cells were either uninfected or infected with Ad0, Ad
PykM, or AdBtk (m.o.i. of 100) and activated with LPS
for 4 h. 5  g/ml actinomycin D was added to stop any fur-
ther mRNA synthesis and the cells were incubated for an
additional 0, 15, 30, 60, 90, or 120 min, after which time
they were harvested in RNA lysis buffer and the superna-
tants were reserved for TNF  ELISA. Total mRNA was
prepared and Taqman RT-PCR was used to access the
quantity of TNF . The results were normalized to 100% at
the 0-min time point. The lines are representative of Con-
trol ( ), Ad0 ( ), Btk ( ), and PykM (x). Data are means
of triplicate reactions   SD expressed as a percentage of
the control and are representative of three experiments
performed using different donors. (B) PBMCs from XLA
and normal male donors or (C) M-CSF monocytes in-
fected with AdBtk or AdPyk2, were stimulated with LPS
for 20 min, lysed, and sequentially immunoblotted for the
indicated proteins. These results are representative of three
different experiments. T
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known to interact with a wide range of signal transduction
molecules (18), we took the alternate approach of examin-
ing the effect of Btk on the UTRs of TNF . Using the 5 
promoter-luciferase and 5   promoter-luciferase-3   UTR
adenoviral reporter constructs, we were able to show that
the ability of Btk to enhance TNF  production required
the 3  UTR. There is considerable evidence indicating that
some of these may occur at the translational level and be
mediated by AU-rich elements (AREs) in the 3  UTR of
the mRNA. Certain inflammatory gene mRNAs, includ-
ing cyclooxygenase-2, IL-6, IL-8, and TNF  mRNAs, are
stabilized by activation of the p38 MAPK pathway by stim-
uli such as IL-1 and LPS (37, 41–43). Studies with mRNA
reporter constructs have shown that the p38 MAPK-medi-
ated stabilization directly involves AREs (38). Thus, AREs
confer instability on mRNAs. However, after activation of
the p38 MAPK pathway, they allow mRNA stabilization
and hence increased protein expression. There is also a
strong association between Btk and p38 MAPK in B cells
showing that the activation of p38 MAPK was completely
inhibited in cells deficient in Lyn and Btk, and the intro-
duction of wild-type Btk, but not kinase-inactive Btk, re-
stored the p38 MAPK activation in response to 280 nm
UV irradiation in chicken DT40 B cells (44). The precise
regions of the TNF 3  UTR involved in this interaction
with Btk and the potential involvement of p38 MAPK and
other intermediary molecules is a field of ongoing research
in our laboratory.
The proposition that Btk is essential for LPS-induced
TNF  production is not easily reconciled with the XLA
phenotype that shows no obvious gross defect of the innate
immune system. However, there have been limited reports
that XLA patients have reduced inflammatory responses
(45). This is in contrast to patients with common variable
immunodeficiency who are prone to multiorgan granulo-
matous disease, although they too have a type of antibody
deficiency similar to the XLA patients (28, 46). In humans,
Btk is absolutely required for the progression of developing
B cells through the pro-B to pre-B stage. However, in xid
mice the absence of Btk alone does not result in the same
phenotype and it is only when Tec is also ablated that the
same B cell deficiency is observed (40). It would be of in-
terest to investigate LPS responsiveness in monocyte/mac-
rophages from these mice. This suggests that Tec might be
able to substitute for the absence of Btk in mouse pro-B
cells, but at this stage of development in man, Tec is either
unavailable or is incapable of substituting for Btk (47). It is
of interest to note that monocyte differentiation toward
macrophages ablates the differences observed between the
XLA patients and normal donors (Fig. 6 A) and that this is
accompanied by an increase in Tec levels (Fig. 6 B). The
observation that Tec kinase is expressed in resting mono-
cytes from XLA and normal individuals, although at a
lower level, may explain why there is some response to
LPS in the Btk-deficient cells. The data obtained here
would suggest that without an increase in Tec kinase ex-
pression induced by M-CSF, there is insufficient kinase ac-
tivity in the resting XLA monocytes to support a full LPS
response. This hypothesis is supported by the observation
that at the lowest LPS concentration used in this study (0.1
ng/ml), TNF  production by XLA and normal cells was
similar (Fig. 1 A). The majority of the studies in mice (23,
24), with the exception of the study by Mukhopadhyay et
al. (25), have been unable to find any differences in LPS re-
sponsiveness between xid and normal macrophages. We
also examined the responsiveness of peritoneal macro-
phages from xid mice versus normal mice and were unable
to observe any differences in TNF  production and NF- B
DNA binding activity in response to LPS (unpublished
data). Taken together, these data suggest that rather than a
difference between murine and human cells, that it is in
fact a difference between monocytes and macrophages. It is
therefore possible that the up-regulation of Tec, or other
Tec kinase family members, in human macrophages may
explain why there is no major impairment of innate immu-
nity in XLA patients although further work is required to
confirm this hypothesis.
In summary, this study has demonstrated that Btk is not
only another tyrosine kinase activated by LPS, but also that
deficiency in its expression is associated with impairment of
Figure 6. The effect of M-CSF treatment on LPS-stimulated TNF 
production and Tec expression. (A) Adherent monocytes from XLA and
normal donors were either stimulated with LPS for 2 h, or incubated with
M-CSF for 48 h before LPS stimulation for 2 h. Supernatants were as-
sayed for TNF  production. (B) Adherent monocytes from normal (lanes
1 and 2) and XLA donors (lanes 3 and 4) were either lysed immediately,
or after M-CSF treatment for 48 h. Western blot analysis was performed
using either  -TecSH3,  -Btk, or  -actin antibody. (C) Elutriated mono-
cytes from normal donors were stimulated with LPS for the indicated time
periods. Tec was immunoprecipitated and in vitro autokinase assay was per-
formed. Each study is representative of at least three separate experiments.T
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TNF  expression. Furthermore, overexpression of Btk in
macrophages synergizes with LPS to induce TNF  pro-
duction by stabilizing TNF  mRNA. Although these data
imply that Btk is the first described tyrosine kinase having a
key role in LPS-induced production of TNF  by mono-
cytes, this role is probably not restricted to Btk alone. The
intriguing question remains as to what role Tec kinases
may have in mediating TNF  production by myeloid cells
to other stimuli, particularly those involved in inflamma-
tory conditions like rheumatoid arthritis and Crohn’s dis-
ease, where TNF  is a validated therapeutic target.
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